N/A N=37 Ventriculostomies in SAH: ICP Open or Not?
Subarachnoid Hemorrhage
Primary: Cerebral Artery Vasospasm — 16; 7 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=5 Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters
Hydrocephaly
Primary: To Demonstrate That the Flusher Can be Primed, Connected, and Activated in a Sterile Clinical Setting Per the Instructions for Use by the Treating Investigator . — 4; 4…
Phase 4 N=434 Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System
Intraventricular Hemorrhage · Subarachnoid Hemorrhage
Primary: Number of Infections — 4; 5; 4; 5 Infections
N/A N=33 FILtration of Subarachnoid Hemorrhage Via SpinaL CAtheteR Extension
Subarachnoid Hemorrhage
Primary: Mean Change in Cisternal Blood From Enrollment to Catheter Removal — -64.7 percent change
N/A N=141 Assessment of CSF Shunt Flow With Thermal Measurements B
Hydrocephalus
Primary: Study Device Sensitivity — 88.9 percent of ground truth positive cases
N/A N=44 Assessment of CSF Shunt Flow With Thermal Measurements A
Hydrocephalus
Primary: Study Device Sensitivity — 88 percent
Phase 2 N=10 Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid
Pharmacokinetics
Primary: Unbound Ceftolozane Exposure in the Plasma — 322.6 mg*h/L
N/A N=117 External Ventricular Drainage Post-Market Clinical Follow-up Registry
Cerebrospinal; Disorder
Primary: Anticipated Drainage of Cerebrospinal Fluid (CSF) — 116 Participants
N/A N=433 A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of Hydrocephalus
Hydrocephalus
Primary: Number of Subjects With Shunt Infections — 14 participants
N/A N=5 Non-invasive Estimation of CSF Pressure Using MRI in Patients With Spontaneous Intracranial Hypotension
Intracranial Hypotension
Primary: Intracranial Pressure Measurements Estimated by the MRICP Technique. — 6.5 cm H20
N/A N=14 Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer
Breast Cancer · Leptomeningeal Metastasis
Primary: Total Number of Participants With Leptomeningeal Metastasis Detected (ER Status) — 3; 1 Participants
N/A N=8 Cerebrospinal Fluid (CSF) Pharmacokinetics of Antimicrobials in Children
Infections
Primary: CSF:Serum Ratio of Vancomycin — 0.08 ratio
N/A N=47 Measuring Signatures in the Fluid Surrounding the Spinal Cord in Patients Who Have Problems With Intrathecal Drug Delivery
Cerebral Palsy · Multiple Sclerosis · Traumatic Brain Injury
Primary: Classification of Catheter Function by CSF Signatures vs. Physician's Standard Trouble-shooting Diagnosis — 13; 16 Subjects whose CSF data agree with MD Dx
N/A N=50 Bactiseal Catheter Safety Registry in China
Hydrocephalus
Primary: 50 Participants With Non-infection Within One Year — 1 Participants
N/A N=50 The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures
Lumbar Puncture
Primary: The First Puncture Success Rate — 79.5 percentage of procedures
N/A N=165 Passive Disinfection Cap Compliance Study
Infection, Hospital
Primary: Disinfecting Barrier Cap Compliance — 98.43 percentage of connector with compliance
N/A N=25 Catheter Placement for Hepatic Hydrothorax
Pleural Effusion
Primary: Feasibility of Using Indwelling Tunneled Pleural Catheters for the Management of Hepatic Hydrothorax — 25 Participants
Phase 4 N=27 Intrathecal (IT) Baclofen Drug Distribution
Muscle Spasticity
Primary: Subjects Experiencing Maximal MAS Change From Baseline - Spasticity of Cerebral Origin — 8; 7; 3; 3 Participants
N/A N=70 A Prospective Randomized Study on the Clinical Benefits of OrthoPAT Drains
Spine Deformity
Primary: Volume of Allogenic Blood Transfused Postoperatively — 458.33; 382.35 mL
N/A N=162 Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
Arnold-Chiari Malformation, Type 1 · Chiari Malformation Type I · Type I Arnold-Chiari Malformation
Primary: The Number of Participants With Surgical Complications — 8; 10 Participants
Phase 2 N=75 Fibrin Sealant for the Sealing of Dura Sutures
Pathological Processes in the Posterior Fossa · Dura Defects
Primary: Incidence of Cerebrospinal Fluid (CSF) Leakage Observed After Surgery — 74.07; 78.13 percentage of participants — p=0.7159
N/A N=80 Comparison of Tesio and LifeCath Twin Permanent Dialysis Catheters
Hemodialysis
Primary: Blood Flow Rate at First Use After Insertion — 277; 383 mL/min
N/A N=68 Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients
Intracranial Aneurysm · Brain Edema · Scoliosis
Primary: Number of ICU Stays Greater Than 1.5 Days — 13; 20 Number of ICU Stays greater that 1.5 Day
N/A N=22 Evaluation of a Novel Sutureless Drain Securement Device
Skin Injury
Primary: Time it Takes to Secure and Dress Each Drain in Totality — 67; 79; 114; 94 Seconds
N/A N=100 Vacuum vs Manual Drainage During Unilateral Thoracentesis
Pleural Effusion · Pleural Diseases · Thoracic Diseases
Primary: Pain Change — 0.53; 1.43 Pre-post NPRS Pain Scale Score
N/A N=107 Use of The Spanner Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men
Urinary Retention
Primary: Number of Participants Who Achieved Post-void Residual (PVR) of ≤150 ml Over 90 Days — 79 Participants
N/A N=599 Dialysis Catheter Comparative Clinical Trial
End Stage Renal Disease
Primary: First Catheter Induced Complication — 78; 77 percentage of participants
Phase 2 N=94 A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery
Coronary Artery Disease · Heart Valve Disease
Primary: Amount of Postoperative Bleeding — 868.9; 1467.6 mL
Phase 2 N=61 Multifaceted Treatment of Catheter-related Urinary Tract Infection
Spinal Cord Injury · Neurogenic Bladder · Urinary Tract Infection
Primary: The Primary Efficacy Outcome of the Study is Response to Treatment Which Will be Assessed at the End of Therapy. Successful Response to Treatment is Defined as…
N/A N=10 Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome
Hunter Syndrome
Primary: Levels of Total Glycosaminoglycan (GAG) in CSF — 816.750 ng/mL